These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23746430)

  • 21. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2.
    Kenna GA; McGeary JE; Swift RM
    Am J Health Syst Pharm; 2004 Nov; 61(22):2380-8. PubMed ID: 15581261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.
    Prescrire Int; 2009 Oct; 18(103):222-3. PubMed ID: 19882797
    [No Abstract]   [Full Text] [Related]  

  • 23. Nalmefene for the treatment of alcohol dependence: a current update.
    Soyka M
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):675-84. PubMed ID: 24246244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy of alcoholism - an update on approved and off-label medications.
    Soyka M; Müller CA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1187-1199. PubMed ID: 28658981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy of alcohol dependence: a review of the clinical data.
    Mann K
    CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topiramate for the treatment of alcohol dependence: comparison with naltrexone.
    Flórez G; Saiz PA; García-Portilla P; Alvarez S; Nogueiras L; Bobes J
    Eur Addict Res; 2011; 17(1):29-36. PubMed ID: 20975274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of abstinence, no heavy drinking days, and a 2-level reduction in World Health Organization drinking levels during treatment for alcohol use disorder in the COMBINE study.
    Wallach JD; Gueorguieva R; Phan H; Witkiewitz K; Wu R; O'Malley SS
    Alcohol Clin Exp Res; 2022 Jul; 46(7):1331-1339. PubMed ID: 35616436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: results from a pilot study.
    Janiri L; Martinotti G; Di Nicola M
    J Clin Psychopharmacol; 2007 Oct; 27(5):519-20. PubMed ID: 17873691
    [No Abstract]   [Full Text] [Related]  

  • 31. Nalmefene in alcohol-dependent patients with a high drinking risk: Randomized controlled trial.
    Miyata H; Takahashi M; Murai Y; Tsuneyoshi K; Hayashi T; Meulien D; Sørensen P; Higuchi S
    Psychiatry Clin Neurosci; 2019 Nov; 73(11):697-706. PubMed ID: 31298784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotics for primary alcohol dependence: a systematic review and meta-analysis of placebo-controlled trials.
    Kishi T; Sevy S; Chekuri R; Correll CU
    J Clin Psychiatry; 2013 Jul; 74(7):e642-54. PubMed ID: 23945459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol-Dependent Men.
    Anthenelli RM; Heffner JL; Wong E; Tibbs J; Russell K; Isgro M; Dinh E; Wehrle C; Worley MJ; Doran N
    Alcohol Clin Exp Res; 2017 Jan; 41(1):197-206. PubMed ID: 28029173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ▼Nalmefene for alcohol dependence.
    Drug Ther Bull; 2014 May; 52(5):54-7. PubMed ID: 24809337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medications for treating alcohol dependence.
    Williams SH
    Am Fam Physician; 2005 Nov; 72(9):1775-80. PubMed ID: 16300039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug therapy of alcohol dependence--a critical review].
    Salaspuro M
    Duodecim; 2003; 119(24):2503-7. PubMed ID: 14870516
    [No Abstract]   [Full Text] [Related]  

  • 39. Nalmefene. Alcohol dependence: no advance.
    Prescrire Int; 2014 Jun; 23(150):150-2. PubMed ID: 25121147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Misuse of alcohol and new drug treatments].
    Paille F
    Rev Prat; 2011 Dec; 61(10):1386-91. PubMed ID: 22288352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.